Related Experiment Video

Updated: Jul 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling

W Jin1, C Yun, M-K Kwak

  • 1Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.

Oncogene
|June 5, 2007
PubMed

Insights

TrkC overexpression drives cancer by inhibiting TGF-beta tumor suppressor activity. This neurotrophin receptor binds to TbetaRII, blocking crucial TGF-beta signaling pathways necessary for tumor suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • TrkC receptor tyrosine kinase overexpression is linked to tumorigenesis and metastasis.
  • The ETV6-NTRK3 fusion protein, a known oncoprotein, suppresses transforming growth factor-beta (TGF-beta) signaling.
  • The precise mechanism by which TrkC influences oncogenesis remains largely unelucidated.

Purpose of the Study:

  • To investigate the role of TrkC in regulating TGF-beta signaling pathways.
  • To elucidate the mechanism through which TrkC affects TGF-beta-mediated tumor suppression.

Main Methods:

  • Utilized small interfering RNA (siRNA) to silence TrkC expression in metastatic 4T1 mammary tumor cells.
  • Assessed Smad2/3 phosphorylation and transcriptional activation in response to TGF-beta stimulation.
  • Investigated the direct interaction between TrkC and the type II TGF-beta receptor (TbetaRII) using co-immunoprecipitation or similar biochemical assays.

Main Results:

  • TrkC expression was found to suppress TGF-beta-induced Smad2/3 phosphorylation and transcriptional activation.
  • Silencing TrkC in 4T1 cells enhanced TGF-beta signaling and restored its growth inhibitory effects.
  • TrkC directly binds to TbetaRII, inhibiting its interaction with the type I TGF-beta receptor (TbetaRI).

Conclusions:

  • TrkC acts as an inhibitor of TGF-beta's tumor suppressor functions.
  • TrkC-mediated inhibition of TGF-beta signaling contributes to cancer progression and metastasis.

More Related Videos

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation09:40

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation

Published on: June 27, 2017

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...